Treatment of Helicobacter pylori infection is important for the management of gastrointestinal disorders such as peptic ulcer and gastric cancer. Due to the increase in the prevalence of H. pylori resistance to antibiotics, triple therapy with clarithromycin is no longer the best treatment for H. pylori, especially in some areas where the local resistance to this antibiotic is higher than 20%. Alternative treatments have been proposed for the eradication of H. pylori. Some of them including novel antibiotics or classical ones in different combinations; these treatments are being used in the regular clinical practice as novel and more effective treatments. Others therapies are using probiotics associated to antibiotics to treat this infection. The present article is a revision of H. pylori eradication treatment, focusing on emerging approaches to avoid the treatment failure, using new therapies with antimicrobials or with probiotics.
27 March 2019 in Applied Microbiology and Biotechnology
The aim of this research was to analyze the antioxidant and prebiotic properties of lactobionic acid and to develop a method of producing it from whey using the bacterium Pseudomonas taetrolens. Prebiotic properties were tested with selected bacterial strains that exhibit probiotic properties, while the antioxidant efficacy was tested using cold-pressed rapeseed oil. A particularly evident prebiotic effect was observed with the bacterium Lactobacillus fermentum with a lactobionic acid concentration of 16 mg/cm3. The growth curves of microorganisms in a substrate with various levels of lactobionic acid showed similarities between Lactococcus lactis, Lactobacillus acidophilus DSM 20242, Lactobacillus acidophilus L-AH1, Lactobacillus acidophilus NCDO, Lactobacillus delbrueckii A, Lactobacillus casei, Lactobacillus casei Shirota, Bifidobacterium bifidum DSM 20215, and Bifidobacterium bifidum DSM 20456, where a short logarithmic growth phase could be distinguished, in comparison to the growth of Lactobacillus fermentum and Lactobacillus acidophilus CH-5, where the logarithmic growth phase was extended. Bifidobacterium bifidum DSM 20082 and Bifidobacterium bifidum DSM 20239 form a separate group. The greater the amount of lactobionic acid added, the higher its activity. The greatest oxidation inhibition efficacy in rapeseed oil was recorded on day 10 of storage at 60 °C with an acid content of 10 mg/cm3. Expressed as a percentage reduction of peroxide value, this effect was 19.6%. The best result for preparations of lactobionic acid were found at 1 cm3 (22.03 mg/cm3), amounting to 7.3% on day 10 of the rapeseed oil thermostat test.
1 July 2014 in Applied Biochemistry and Biotechnology
Lactobionic acid is a relatively new product derived from lactose oxidation, with high potential applications as a bioactive compound. Conducted experiments confirmed that both the time and temperature influenced the production of lactobionic acid during bioconversion of lactose using the Pseudomonas taetrolens bacteria. The study also investigated the effect of inoculum concentration on the production of lactobionic acid as a result of oxidation of whey-derived lactose. The highest concentration of lactobionic acid during oxidation of whey-derived lactose at a temperature of 30 °C by microorganisms. P. taetrolens was obtained during 50-h oxidation of the medium, which contained 25 % addition of the inoculum, in which the count of live cells was 2.85 × 109 CFU/ml.
Objectives To use the glucose–fructose oxidoreductase (GFOR) from Zymomonas mobilis and expressed in Escherichia coli for lactobionic acid production by conversion of lactose from whey. Results The highest concentrations of lactobionic acid (3.2 mg ml−1) during oxidation of whey-derived lactose by E. coli was at 24 h. Introduction of GFOR gene from Z. mobilis, into E. coli improved enzyme yields compared to what is obtainable by fermentation of the donor strain. The production of lactobionic acid by E. coli was 2.6-times higher than by Z. mobilis. Conclusions Recombinants of E. coli overexpressing the GFOR gene from Z. mobilis produced higher amount of lactobionoic acid from whey-derived lactose.
14 November 2023 in European Journal of Pharmaceutics and Biopharmaceutics